Mi-Jung Lim

Introduction: Mi-Jung Lim is a distinguished inventor based in Daejeon, South Korea, known for his groundbreaking work in the field of pharmaceutical sciences. With a focus on developing innovative treatments for neurological disorders, Lim has made significant contributions to combatting diseases such as Parkinson's disease.

Latest Patents: Lim holds one patent titled "Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating Parkinson's disease using the same." This patent describes a substituted azole derivative and pharmaceutically acceptable salts that are part of a pharmaceutical composition intended to treat Parkinson's disease in mammals. The compound showcases efficacy against Parkinson's due to its inhibitory effects on MAO-B activity.

Career Highlights: Lim is currently employed at Sk Biopharmaceuticals Co., Ltd., a company recognized for its commitment to research and development in biotechnology and pharmaceuticals. His innovative work has led to advancements that could potentially improve the quality of life for patients suffering from Parkinson's disease.

Collaborations: Throughout his career, Mi-Jung Lim has collaborated with esteemed colleagues, including Cheol-Hyoung Park and Hye-Kyung Min. Their combined expertise contributes to a rich collaborative environment focused on advancing therapeutic strategies in neurological treatments.

Conclusion: Mi-Jung Lim continues to be a notable figure in the pharmaceutical industry, particularly in the realm of Parkinson's disease treatment. His patent and collaborative efforts exemplify the kind of innovative thinking that can lead to significant breakthroughs in medicine. As he pursues further discoveries, the impact of his work holds promise for many individuals affected by neurological challenges.

Profile summary based on public USPTO records.